Analyze Diet
Journal of equine veterinary science2022; 121; 104165; doi: 10.1016/j.jevs.2022.104165

Cartilage-Sparing Properties of Equine Omega Complete in an Organ Culture Model of Cartilage Inflammation.

Abstract: The purpose of this study was to determine anti-inflammatory and/or chondroprotective effects of Equine Omega Complete (EOC) on cartilage explants stimulated with lipopolysaccharide (LPS). Explants were aseptically prepared from the intercarpal joints of 17 market-weight pigs and placed in culture at 37°C for a total of 120 hours. For the final 96 hours, explants were conditioned with a simulated digestion extract of EOC (0, 36 or 180 μL/mL), and for the final 48 hours explants were stimulated with LPS (0 or 15µg/mL). Media was removed and replaced every 24 hours. Samples from the final 48 hours were analyzed for biomarkers of cartilage inflammation (prostaglandin E [PGE] and nitric oxide [NO]) and cartilage structure (glycosaminoglycan [GAG]). At the end of the culture period cartilage explants were stained for an estimate of cell viability. Stimulation of unconditioned explants with LPS significantly increased media concentrations of PGE, GAG and NO compared with that from unstimulated explants. LPS stimulation did not significantly affect cell viability. Both concentrations of EOC prevented significant LPS-stimulated cartilage release of GAG without impairing chondrocyte viability. No other effects of treatment were observed. These data provide evidence for a non-cytotoxic, chondroprotective effect of EOC in cartilage. This in vitro experiment supports the use of EOC in protecting against the detrimental effects of inflammation on cartilage structure.
Publication Date: 2022-11-21 PubMed ID: 36423791DOI: 10.1016/j.jevs.2022.104165Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the benefits of Equine Omega Complete (EOC) in preventing inflammation-induced damage to cartilage. The tests, conducted on pig cartilage, indicate that EOC can help maintain cartilage structure amid inflammatory conditions without affecting cell viability.

Objective of the Study

  • The aim of the study was to verify the potential anti-inflammatory and chondroprotective (cartilage-protecting) attributes of Equine Omega Complete (EOC), particularly its capacity to shield cartilage from the harmful effects of inflammation. This was analyzed in a lipopolysaccharide (LPS)-stimulated culture model of cartilage inflammation.

Methodology of the Study

  • Cartilage explants were prepared from the joints of 17 market-weight pigs aseptically and cultivated at a temperature of 37°C for a total of 120 hours.
  • For the last 96 hours, these explants were conditioned with a simulated digestion extract of EOC at concentrations of 0, 36, or 180 μL/mL. In the final 48 hours, they were stimulated with LPS at 0 or 15µg/mL.
  • The culture medium was changed every 24 hours, and samples taken from the final 48 hours were examined for biomarkers of cartilage inflammation (prostaglandin E [PGE] and nitric oxide [NO]) as well as for cartilage structure (glycosaminoglycan [GAG]).
  • At the end of the experiment, cartilage explants were stained to estimate cell viability.

Findings

  • The unconditioned explants stimulated with LPS exhibited a substantial increase in PGE, GAG, and NO levels compared to the unstimulated explants. However, this LPS stimulation did not significantly affect cell viability.
  • In both concentrations, EOC successfully prevented a significant LPS-stimulated release of GAG from the cartilage, while not impairing chondrocyte viability.
  • Other than this, no notable effects of the treatment were found.

Conclusion

  • The research data points to EOC’s non-cytotoxic, chondroprotective effect on cartilage.
  • This in vitro study indicates that EOC could be effective in shielding the structure of cartilage from the destructive effects of inflammation, suggesting its potential usage in protecting cartilage health.

Cite This Article

APA
Garland A, Wierenga C, McCrae P, Pearson W. (2022). Cartilage-Sparing Properties of Equine Omega Complete in an Organ Culture Model of Cartilage Inflammation. J Equine Vet Sci, 121, 104165. https://doi.org/10.1016/j.jevs.2022.104165

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 121
Pages: 104165
PII: S0737-0806(22)00301-X

Researcher Affiliations

Garland, Anna
  • Department of Animal Biosciences, University of Guelph, Guelph, Ontario, Canada.
Wierenga, Corina
  • Department of Animal Biosciences, University of Guelph, Guelph, Ontario, Canada.
McCrae, Persephone
  • Department of Animal Biosciences, University of Guelph, Guelph, Ontario, Canada.
Pearson, Wendy
  • Department of Animal Biosciences, University of Guelph, Guelph, Ontario, Canada. Electronic address: wpearson@uoguelph.ca.

MeSH Terms

  • Animals
  • Horses
  • Swine
  • Organ Culture Techniques / veterinary
  • Lipopolysaccharides / pharmacology
  • Lipopolysaccharides / therapeutic use
  • Cartilage
  • Inflammation / drug therapy
  • Inflammation / veterinary
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Glycosaminoglycans / pharmacology
  • Glycosaminoglycans / therapeutic use
  • Horse Diseases / drug therapy
  • Swine Diseases

Conflict of Interest Statement

Declaration of Competing Interest The authors declare no conflicts of interest.

Citations

This article has been cited 1 times.
  1. Crosbie M, Vanderboom K, Souccar-Young J, Pearson W. Integrating Cartilage Explant Culture with Simulated Digestion and Hepatic Biotransformation Refines In Vitro Screening of Joint Care Nutraceuticals. Methods Protoc 2025 Aug 6;8(4).
    doi: 10.3390/mps8040091pubmed: 40863741google scholar: lookup